Affinity Biologicals, a Manufacturer of Thrombosis and Hemostasis Research Products, Announces Involvement in the ISTH SSC 2016 Meeting
The 62nd Annual Meeting of the Scientific and Standardization Committee (SSC) of the International Society of Thrombosis and Hemostasis (ISTH) begins on May 25th in Montpelier, France, and will continue through to the 28th. Affinity Biologicals will participate in the event through a discussion of products with clients and networking with other researchers in the field.
In addition to the discussion of emerging countries, the SSC will include several informational sessions about new hemostasis research, and new drugs in the approval pipeline. Sam Schulman and Andreas Greinacher will examine controversies surrounding oral anti-coagulants. Nigel Key and Robert Medcalf will deliver an overview of the newest treatment options. Roundtable discussions of critical issues in the field of thrombosis and hemostasis research will fill the afternoon and evening hours, creating a full slate of events for attendees.
For Affinity Biologicals, the conference is a chance to meet face-to-face with the international clients who utelize Affinity Biologicals' products their research.
About Affinity Biologicals
Affinity Biologicals is the manufacturer of numerous products used in thrombosis and hemostasis research and diagnostic testing. Affinity Biologicals offers a diverse line research products and diagnostic test products, including antibody and ELISA test kits, as well as immuno-depleted plasmas and matched pair antibodies.
For more information, please visit www.affinitybiologicals.com or call (905) 304-9896.